| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 10 |
| NetGPI | no | yes: 0, no: 10 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0016020 | membrane | 2 | 2 |
| GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QHE1
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0002097 | tRNA wobble base modification | 7 | 3 |
| GO:0002100 | tRNA wobble adenosine to inosine editing | 8 | 3 |
| GO:0006139 | nucleobase-containing compound metabolic process | 3 | 3 |
| GO:0006382 | adenosine to inosine editing | 7 | 3 |
| GO:0006396 | RNA processing | 6 | 3 |
| GO:0006399 | tRNA metabolic process | 7 | 3 |
| GO:0006400 | tRNA modification | 6 | 3 |
| GO:0006725 | cellular aromatic compound metabolic process | 3 | 3 |
| GO:0006807 | nitrogen compound metabolic process | 2 | 3 |
| GO:0008033 | tRNA processing | 8 | 3 |
| GO:0008152 | metabolic process | 1 | 3 |
| GO:0009451 | RNA modification | 5 | 3 |
| GO:0009987 | cellular process | 1 | 3 |
| GO:0016070 | RNA metabolic process | 5 | 3 |
| GO:0016553 | base conversion or substitution editing | 6 | 3 |
| GO:0034470 | ncRNA processing | 7 | 3 |
| GO:0034641 | cellular nitrogen compound metabolic process | 3 | 3 |
| GO:0034660 | ncRNA metabolic process | 6 | 3 |
| GO:0043170 | macromolecule metabolic process | 3 | 3 |
| GO:0043412 | macromolecule modification | 4 | 3 |
| GO:0044237 | cellular metabolic process | 2 | 3 |
| GO:0044238 | primary metabolic process | 2 | 3 |
| GO:0046483 | heterocycle metabolic process | 3 | 3 |
| GO:0071704 | organic substance metabolic process | 2 | 3 |
| GO:0090304 | nucleic acid metabolic process | 4 | 3 |
| GO:1901360 | organic cyclic compound metabolic process | 3 | 3 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0003824 | catalytic activity | 1 | 11 |
| GO:0004000 | adenosine deaminase activity | 4 | 3 |
| GO:0008251 | tRNA-specific adenosine deaminase activity | 5 | 3 |
| GO:0016787 | hydrolase activity | 2 | 9 |
| GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 3 | 3 |
| GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 4 | 3 |
| GO:0019239 | deaminase activity | 3 | 3 |
| GO:0052717 | tRNA-specific adenosine-34 deaminase activity | 6 | 2 |
| GO:0005488 | binding | 1 | 2 |
| GO:0008270 | zinc ion binding | 6 | 2 |
| GO:0043167 | ion binding | 2 | 2 |
| GO:0043169 | cation binding | 3 | 2 |
| GO:0046872 | metal ion binding | 4 | 2 |
| GO:0046914 | transition metal ion binding | 5 | 2 |
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 278 | 280 | PF00675 | 0.575 |
| CLV_PCSK_KEX2_1 | 276 | 278 | PF00082 | 0.561 |
| CLV_PCSK_PC1ET2_1 | 276 | 278 | PF00082 | 0.549 |
| CLV_PCSK_SKI1_1 | 11 | 15 | PF00082 | 0.233 |
| CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.266 |
| DEG_SCF_FBW7_1 | 140 | 147 | PF00400 | 0.430 |
| DOC_CKS1_1 | 141 | 146 | PF01111 | 0.433 |
| DOC_USP7_MATH_1 | 112 | 116 | PF00917 | 0.475 |
| DOC_USP7_MATH_1 | 145 | 149 | PF00917 | 0.501 |
| DOC_USP7_MATH_1 | 211 | 215 | PF00917 | 0.590 |
| DOC_USP7_MATH_1 | 222 | 226 | PF00917 | 0.638 |
| DOC_USP7_MATH_1 | 46 | 50 | PF00917 | 0.451 |
| DOC_USP7_UBL2_3 | 276 | 280 | PF12436 | 0.554 |
| DOC_WW_Pin1_4 | 136 | 141 | PF00397 | 0.522 |
| DOC_WW_Pin1_4 | 194 | 199 | PF00397 | 0.518 |
| DOC_WW_Pin1_4 | 225 | 230 | PF00397 | 0.670 |
| LIG_14-3-3_CanoR_1 | 136 | 140 | PF00244 | 0.350 |
| LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.442 |
| LIG_FHA_1 | 141 | 147 | PF00498 | 0.436 |
| LIG_FHA_2 | 251 | 257 | PF00498 | 0.412 |
| LIG_LIR_Gen_1 | 39 | 47 | PF02991 | 0.466 |
| LIG_LIR_Gen_1 | 93 | 101 | PF02991 | 0.392 |
| LIG_LIR_Nem_3 | 151 | 155 | PF02991 | 0.448 |
| LIG_LIR_Nem_3 | 241 | 246 | PF02991 | 0.526 |
| LIG_LIR_Nem_3 | 39 | 45 | PF02991 | 0.466 |
| LIG_LIR_Nem_3 | 93 | 97 | PF02991 | 0.392 |
| LIG_Pex14_1 | 242 | 246 | PF04695 | 0.514 |
| LIG_PTB_Apo_2 | 179 | 186 | PF02174 | 0.347 |
| LIG_REV1ctd_RIR_1 | 175 | 182 | PF16727 | 0.510 |
| LIG_SH2_CRK | 170 | 174 | PF00017 | 0.413 |
| LIG_SH2_CRK | 42 | 46 | PF00017 | 0.433 |
| LIG_SH2_NCK_1 | 170 | 174 | PF00017 | 0.510 |
| LIG_SH2_PTP2 | 155 | 158 | PF00017 | 0.415 |
| LIG_SH2_STAP1 | 42 | 46 | PF00017 | 0.433 |
| LIG_SH2_STAT5 | 152 | 155 | PF00017 | 0.415 |
| LIG_SH2_STAT5 | 246 | 249 | PF00017 | 0.412 |
| LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.366 |
| LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.316 |
| LIG_SH3_1 | 267 | 273 | PF00018 | 0.589 |
| LIG_SH3_3 | 138 | 144 | PF00018 | 0.507 |
| LIG_SH3_3 | 205 | 211 | PF00018 | 0.585 |
| LIG_SH3_3 | 267 | 273 | PF00018 | 0.589 |
| LIG_SUMO_SIM_anti_2 | 256 | 262 | PF11976 | 0.368 |
| LIG_TRAF2_1 | 20 | 23 | PF00917 | 0.510 |
| LIG_TYR_ITIM | 153 | 158 | PF00017 | 0.415 |
| LIG_TYR_ITIM | 168 | 173 | PF00017 | 0.415 |
| LIG_WRC_WIRS_1 | 6 | 11 | PF05994 | 0.183 |
| MOD_CDK_SPK_2 | 194 | 199 | PF00069 | 0.308 |
| MOD_CK1_1 | 116 | 122 | PF00069 | 0.456 |
| MOD_CK1_1 | 139 | 145 | PF00069 | 0.463 |
| MOD_CK1_1 | 214 | 220 | PF00069 | 0.618 |
| MOD_CK1_1 | 225 | 231 | PF00069 | 0.694 |
| MOD_CK2_1 | 119 | 125 | PF00069 | 0.375 |
| MOD_CK2_1 | 227 | 233 | PF00069 | 0.605 |
| MOD_CK2_1 | 250 | 256 | PF00069 | 0.421 |
| MOD_GlcNHglycan | 109 | 113 | PF01048 | 0.330 |
| MOD_GlcNHglycan | 212 | 216 | PF01048 | 0.575 |
| MOD_GSK3_1 | 108 | 115 | PF00069 | 0.474 |
| MOD_GSK3_1 | 135 | 142 | PF00069 | 0.527 |
| MOD_GSK3_1 | 221 | 228 | PF00069 | 0.667 |
| MOD_GSK3_1 | 47 | 54 | PF00069 | 0.451 |
| MOD_N-GLC_1 | 187 | 192 | PF02516 | 0.357 |
| MOD_N-GLC_1 | 37 | 42 | PF02516 | 0.307 |
| MOD_N-GLC_1 | 79 | 84 | PF02516 | 0.215 |
| MOD_NEK2_1 | 221 | 226 | PF00069 | 0.561 |
| MOD_NEK2_1 | 69 | 74 | PF00069 | 0.466 |
| MOD_NEK2_2 | 37 | 42 | PF00069 | 0.492 |
| MOD_OFUCOSY | 66 | 73 | PF10250 | 0.233 |
| MOD_PIKK_1 | 206 | 212 | PF00454 | 0.672 |
| MOD_PKA_2 | 135 | 141 | PF00069 | 0.433 |
| MOD_PKB_1 | 77 | 85 | PF00069 | 0.428 |
| MOD_Plk_1 | 37 | 43 | PF00069 | 0.504 |
| MOD_Plk_4 | 187 | 193 | PF00069 | 0.355 |
| MOD_Plk_4 | 37 | 43 | PF00069 | 0.507 |
| MOD_Plk_4 | 5 | 11 | PF00069 | 0.315 |
| MOD_ProDKin_1 | 136 | 142 | PF00069 | 0.522 |
| MOD_ProDKin_1 | 194 | 200 | PF00069 | 0.526 |
| MOD_ProDKin_1 | 225 | 231 | PF00069 | 0.669 |
| TRG_DiLeu_BaEn_1 | 256 | 261 | PF01217 | 0.380 |
| TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.415 |
| TRG_ENDOCYTIC_2 | 170 | 173 | PF00928 | 0.415 |
| TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.466 |
| TRG_ER_diArg_1 | 277 | 279 | PF00400 | 0.597 |
| TRG_NLS_MonoCore_2 | 275 | 280 | PF00514 | 0.573 |
| TRG_NLS_MonoExtC_3 | 275 | 280 | PF00514 | 0.548 |
| TRG_NLS_MonoExtN_4 | 273 | 280 | PF00514 | 0.538 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P6V2 | Leptomonas seymouri | 47% | 86% |
| A0A1X0NRT1 | Trypanosomatidae | 49% | 100% |
| A0A3S7WR79 | Leishmania donovani | 89% | 100% |
| A0A422NWX1 | Trypanosoma rangeli | 44% | 100% |
| A4H663 | Leishmania braziliensis | 74% | 100% |
| A4HUI5 | Leishmania infantum | 89% | 100% |
| C9ZVK9 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 44% | 100% |
| E9AN83 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
| O94642 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 25% | 72% |
| P47058 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 28% | 100% |
| Q5E9J7 | Bos taurus | 27% | 100% |
| Q5RIV4 | Danio rerio | 28% | 100% |
| Q6P6J0 | Mus musculus | 28% | 100% |
| Q7Z6V5 | Homo sapiens | 27% | 100% |
| V5DKK8 | Trypanosoma cruzi | 44% | 100% |